Published articles

Last updated:

Burton J, Rounge TB, Haugen TB, Wojewodzic MW (2025)

Networks of pre-diagnostic circulating RNA in testicular germ cell tumour

Sci Rep, 15 (1), 1910

DOI 10.1038/s41598-024-84484-z PubMed 39809819

 

Blandino A, Scherer D, Boekstegers F, Rounge TB, Langseth H, Roessler S, Hveem K, Brenner H, Pechlivanis S, Waldenberger M, Bermejo JL (2024)

Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts

European Journal of Cancer, 115138

DOI 10.1016/j.ejca.2024.115138 PubMed 39579640

 

Tsuruda KM, Langseth H, Ursin G, Hofvind S, Fortner RT (2024)

Validity of self-reported number of pregnancies and maternal age at first birth among females attending organized mammographic screening

Scand J Public Health, 14034948241281197

DOI 10.1177/14034948241281197 PubMed 39439148

 

Stawiski K, Fortner RT, Pestarino L, Umu SU, Kaaks R, Rounge TB, Elias KM, Fendler W, Langseth H (2024)

Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches

Front Oncol, 14, 1389066

DOI 10.3389/fonc.2024.1389066 PubMed 11231195

 

Rostami S, Rounge TB, Pestarino L, Lyle R, Fortner RT, Haaland Ø A, Lie RT, Wiklund F, Bjørge T, Langseth H (2024)

Differential levels of circulating RNAs prior to endometrial cancer diagnosis

Int J Cancer

DOI 10.1002/ijc.34951 PubMed 38733362

 

Moen CA, Falkenthal TE, Thorkelsen TK, Hopland A, Rio OE, Honoré A, Juliebø-Jones P, Dongre HN, Costea DE, Bostad L, Brennan P, Johansson M, Ferreiro-Iglesias A, Brenner N, Waterboer T, Nygård M, Beisland C (2023)

Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years

Eur Urol Oncol

DOI 10.1016/j.euo.2023.10.013 PubMed 37949729

 

Wu Z, Trabert B, Guillemette C, Caron P, Bradwin G, Graubard BI, Weiderpass E, Ursin G, Langseth H, McGlynn KA (2023)

Pre-diagnostic hormone levels and risk of testicular germ cell tumors: a nested case-control study in the Janus Serum Bank

Cancer Epidemiol Biomarkers Prev

DOI 10.1158/1055-9965.Epi-23-0772 PubMed 37619591

 

Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, Weinstein SJ, McCullough ML, Eliassen AH, Cook NR, Agnoli C, Almquist M, Black A, Buring JE, Chen C, Chen Y, Clendenen T, Dossus L, Fedirko V, Gierach GL, Giovannucci EL, Goodman GE, Goodman MT, Guénel P, Hallmans G, et al. (2023)

Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts

Eur J Epidemiol, 38 (1), 11-29

DOI 10.1007/s10654-022-00921-1 PubMed 10039648

 

Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023)

Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway

Acta Oncol, 62 (1), 8-14

DOI 10.1080/0284186x.2023.2175331 PubMed 10301241

 

Abu-Halima M, Keller A, Becker LS, Fischer U, Engel A, Ludwig N, Kern F, Rounge TB, Langseth H, Meese E, Keller V (2023)

Dynamic and static circulating cancer microRNA biomarkers - a validation study

RNA Biol, 20 (1), 1-9

DOI 10.1080/15476286.2022.2154470 PubMed 9754110

 

Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, Gunter MJ, Holmes MV, Martin RM, Tsilidis KK, Albanes D, Barricarte A, Bueno-de-Mesquita B, Chen C, Cohn BA, Dimou NL, Ferrucci L, Flicker L, Freedman ND, Giles GG, Giovannucci EL, Goodman GE, Haiman CA, Hankey GJ, Huang J, et al. (2022)

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

Int J Cancer, 151 (7), 1033-1046

DOI 10.1002/ijc.34116 PubMed 7613289

 

Umu SU, Langseth H, Zuber V, Helland Å, Lyle R, Rounge TB (2022)

Serum RNAs can predict lung cancer up to 10 years prior to diagnosis

Elife, 11

DOI 10.7554/eLife.71035 PubMed 8884722

 

Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, Larsson SC, Lee IM, Martínez ME, Merritt MA, Milne RL, O'Brien KM, Orlich MJ, Palmer JR, Patel AV, Peters U, et al. (2022)

Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)

Int J Epidemiol, 51 (3), e73-e86

DOI 10.1093/ije/dyab211 PubMed 9425513

 

Stenehjem JS, Støer NC, Ghiasvand R, Grimsrud TK, Babigumira R, Rees JR, Nilsen LT, Johnsen B, Thorsby PM, Veierød MB, Robsahm TE (2022)

Prediagnostic serum 25-hydroxyvitamin D and leptin in relation to melanoma-specific death and overall death

Pigment Cell Melanoma Res, 35 (2), 280-284

DOI 10.1111/pcmr.13026 PubMed 34978150

 

Simon J, Brenner N, Reich S, Langseth H, Hansen BT, Ursin G, Ferreiro-Iglesias A, Brennan P, Kreimer AR, Johansson M, Pring M, Nygard M, Waterboer T (2022)

Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis

Cancer Epidemiol, 77, 102117

DOI 10.1016/j.canep.2022.102117 PubMed 35121404

 

Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygård M, Bender N, Schroeder L, Hildesheim A, Pawlita M, D'Souza G, Visvanathan K, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Wassertheil-Smoller S, Ness-Jensen E, Hveem K, Grioni S, Kaaks R, Sánchez MJ, Weiderpass E, Giles GG, Milne RL, Cai Q, et al. (2022)

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

J Clin Oncol, 40 (31), 3613-3622

DOI 10.1200/jco.21.01785 PubMed 9622695

 

Langseth H, Kymre K, Slyngstad T, Rounge TB, Gislefoss RE, Lauritzen M (2022)

Janus serumbank – jakten på biomarkører for kreft

Norsk Epidemiologi, 30 (1-2)

DOI 10.5324/nje.v30i1-2.4983

 

Coghill AE, Kim Y, Hodge JM, Bender N, Smith-Warner SA, Teras LR, Grimsrud TK, Waterboer T, Egan KM (2022)

Prospective investigation of herpesvirus infection and risk of glioma

Int J Cancer, 151 (2), 222-228

DOI 10.1002/ijc.33987 PubMed 35225352

 

Xie SH, Ness-Jensen E, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2021)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma

Int J Cancer, 148 (4), 905-913

DOI 10.1002/ijc.33285 PubMed 7820945

 

Wojewodzic MW, Leithaug M, Lauritzen M, Lyle R, Haglund S, Rubin CJ, Ewels PA, Grotmol T, Rounge TB (2021)

Ultralow amounts of DNA from long-term archived serum samples produce high-quality methylomes

Clin Epigenetics, 13 (1), 107

DOI 10.1186/s13148-021-01097-3 PubMed 8114536

 

Langseth H, Umu SU, Bucher-Johannessen C, Babigumira R, Leithaug M, Lauritzen M, Vineis P, Ursin G, Lyle R, Rounge TB (2021)

Data Resource Profile: thousands of circulating RNA profiles of pre-clinical samples from the Janus Serum Bank Cohort

medRxiv, 2021.2001.2022.20243154

DOI 10.1101/2021.01.22.20243154

 

Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, Chen C, Cheng I, Genkinger JM, Giles GG, Huang J, Joshu CE, Key TJ, Knutsen S, Koutros S, Langseth H, Li SX, MacInnis RJ, Markt SC, Penney KL, Perez-Cornago A, Rohan TE, Smith-Warner SA, Stampfer MJ, Stopsack KH, et al. (2021)

Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research

J Natl Cancer Inst, 113 (6), 727-734

DOI 10.1093/jnci/djaa154 PubMed 8248961

 

Hodge JM, Coghill AE, Kim Y, Bender N, Smith-Warner SA, Gapstur S, Teras LR, Grimsrud TK, Waterboer T, Egan KM (2021)

Toxoplasma gondii infection and the risk of adult glioma in two prospective studies

Int J Cancer

DOI 10.1002/ijc.33443 PubMed 33427315

 

Hektoen HH, Robsahm TE, Stenehjem JS, Axcrona K, Babigumira R, Mondul AM, Gislefoss RE, Andreassen BK (2021)

Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort

Cancer Med, 10 (12), 4107-4116

DOI 10.1002/cam4.3960 PubMed 8209600

 

Hektoen HH, Gislefoss RE, Stenehjem JS, Langseth H, Axcrona K, Mondul AM, Robsahm TE, Andreassen BK (2021)

Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort

Clin Epidemiol, 13, 801-811

DOI 10.2147/clep.S319620 PubMed 8449552

 

Gislefoss RE, Berge U, Lauritzen M, Langseth H, Wojewodzic MW (2021)

A Simple and Cost-Effective Method for Measuring Hemolysis in Biobank Serum Specimens

Biopreserv Biobank, 19 (6), 525-530

DOI 10.1089/bio.2021.0037 PubMed 34613836

 

Egan KM, Kim Y, Bender N, Hodge JM, Coghill AE, Smith-Warner SA, Rollison DE, Teras LR, Grimsrud TK, Waterboer T (2021)

Prospective investigation of polyomavirus infection and the risk of adult glioma

Sci Rep, 11 (1), 9642

DOI 10.1038/s41598-021-89133-3 PubMed 8100283

 

Andreassen BK, Hektoen HH, Axcrona K, Langseth H, Stenehjem JS, Robsahm TE (2021)

Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]

Clin Epidemiol, 13, 1061-1062

DOI 10.2147/clep.S345565 PubMed 8599866

 

Xie SH, Ness-Jensen E, Rabbani S, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2020)

Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men

Am J Gastroenterol, 115 (2), 216-223

DOI 10.14309/ajg.0000000000000446 PubMed 31658123

 

Umu SU, Langseth H, Keller A, Meese E, Helland Å, Lyle R, Rounge TB (2020)

A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis

Mol Oncol, 14 (2), 235-247

DOI 10.1002/1878-0261.12620 PubMed 6998662

 

Stenehjem JS, Støer NC, Ghiasvand R, Grimsrud TK, Babigumira R, Rees JR, Nilsen LT, Johnsen B, Thorsby PM, Veierød MB, Robsahm TE (2020)

Prediagnostic serum 25-hydroxyvitamin D and melanoma risk

Sci Rep, 10 (1), 20129

DOI 10.1038/s41598-020-77155-2 PubMed 7676247

 

Schwartz GG, Tretli S, Klug MG, Robsahm TE (2020)

Women who develop ovarian cancer show an increase in serum calcium and a decrease in serum albumin. A longitudinal study in the Janus Serum Bank Cohort

Gynecol Oncol, 159 (1), 264-269

DOI 10.1016/j.ygyno.2020.07.006 PubMed 8296848

 

Rounge TB, Lauritzen M, Erlandsen SE, Langseth H, Holmen OL, Gislefoss RE (2020)

Ultralow amounts of DNA from long-term archived serum samples produce quality genotypes

Eur J Hum Genet, 28 (4), 521-524

DOI 10.1038/s41431-019-0543-x PubMed 7080753

 

Purdue MP, Lan Q, Langseth H, Grimsrud TK, Hildesheim A, Rothman N (2020)

Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes

Int J Cancer, 146 (12), 3312-3319

DOI 10.1002/ijc.32684 PubMed 10123845

 

Niehoff NM, Zabor EC, Satagopan J, Widell A, O'Brien TR, Zhang M, Rothman N, Grimsrud TK, Van Den Eeden SK, Engel LS (2020)

Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts

Environ Res, 187, 109690

DOI 10.1016/j.envres.2020.109690 PubMed 7317661

 

Keller A, Fehlmann T, Backes C, Kern F, Gislefoss R, Langseth H, Rounge TB, Ludwig N, Meese E (2020)

Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis

RNA Biol, 17 (10), 1416-1426

DOI 10.1080/15476286.2020.1771945 PubMed 7549715

 

Irvin SR, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N (2020)

Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank

Cancer Epidemiol Biomarkers Prev, 29 (3), 636-642

DOI 10.1158/1055-9965.Epi-19-0675 PubMed 7060092

 

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)

Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway

Cancer Med, 9 (12), 4420-4432

DOI 10.1002/cam4.3060 PubMed 7300409

 

Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvåle R, George A, Grönberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Taskén KA, Mills IG (2020)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

Eur Urol Open Sci, 21, 51-60

DOI 10.1016/j.euros.2020.08.007 PubMed 8317831

 

Chen D, Grimsrud TK, Langseth H, Barr DB, Bassig BA, Blair A, Cantor KP, Gammon MD, Lan Q, Rothman N, Engel LS (2020)

Prediagnostic serum concentrations of organochlorine pesticides and non-Hodgkin lymphoma: A nested case-control study in the Norwegian Janus Serum Bank Cohort

Environ Res, 187, 109515

DOI 10.1016/j.envres.2020.109515 PubMed 9278122

 

Burton J, Umu SU, Langseth H, Grotmol T, Grimsrud TK, Haugen TB, Rounge TB (2020)

Serum RNA Profiling in the 10-Years Period Prior to Diagnosis of Testicular Germ Cell Tumor

Front Oncol, 10, 574977

DOI 10.3389/fonc.2020.574977 PubMed 7673397

 

Bassig BA, Shu XO, Sjödin A, Koh WP, Gao YT, Adams-Haduch J, Davis M, Wang R, Xiang YB, Engel LS, Purdue MP, Ji BT, Yang G, Jones RS, Langseth H, Hosgood HD, Grimsrud TK, Seow WJ, Wong JYY, Hu W, Chen D, Zheng W, Yuan JM, Lan Q, Rothman N (2020)

Prediagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore

Int J Cancer, 146 (3), 839-849

DOI 10.1002/ijc.32350 PubMed 8244652

 

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, et al. (2019)

A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk

Cancer Res, 79 (1), 274-285

DOI 10.1158/0008-5472.Can-18-2318 PubMed 6330070

 

Robsahm TE, Tretli S, Torjesen PA, Babigumira R, Schwartz GG (2019)

Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis

Clin Epidemiol, 11, 695-705

DOI 10.2147/clep.S207230 PubMed 6690592

 

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, et al. (2019)

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts

J Natl Cancer Inst, 111 (2), 158-169

DOI 10.1093/jnci/djy087 PubMed 6376911

 

Kreimer AR, Ferreiro-Iglesias A, Nygård M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, et al. (2019)

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

Ann Oncol, 30 (8), 1335-1343

DOI 10.1093/annonc/mdz138 PubMed 6683856

 

Engel LS, Zabor EC, Satagopan J, Widell A, Rothman N, O'Brien TR, Zhang M, Van Den Eeden SK, Grimsrud TK (2019)

Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts

Int J Cancer, 145 (9), 2360-2371

DOI 10.1002/ijc.32175 PubMed 6667305

 

Bassig BA, Engel LS, Langseth H, Grimsrud TK, Cantor KP, Vermeulen R, Purdue MP, Barr DB, Wong JYY, Blair A, Rothman N, Lan Q (2019)

Pre-diagnostic serum concentrations of organochlorines and risk of acute myeloid leukemia: A nested case-control study in the Norwegian Janus Serum Bank Cohort

Environ Int, 125, 229-235

DOI 10.1016/j.envint.2019.01.066 PubMed 30721827

 

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, et al. (2018)

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Eur Urol, 74 (5), 585-594

DOI 10.1016/j.eururo.2018.07.024 PubMed 6195673

 

Umu SU, Langseth H, Bucher-Johannessen C, Fromm B, Keller A, Meese E, Lauritzen M, Leithaug M, Lyle R, Rounge TB (2018)

A comprehensive profile of circulating RNAs in human serum

RNA Biol, 15 (2), 242-250

DOI 10.1080/15476286.2017.1403003 PubMed 5798962

 

Swerdlow AJ, Harvey CE, Milne RL, Pottinger CA, Vachon CM, Wilkens LR, Gapstur SM, Johansson M, Weiderpass E, Winn DM (2018)

The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries

Cancer Epidemiol Biomarkers Prev, 27 (11), 1307-1319

DOI 10.1158/1055-9965.Epi-18-0182 PubMed 30721827

 

Stenehjem JS, Veierød MB, Nilsen LT, Ghiasvand R, Johnsen B, Grimsrud TK, Babigumira R, Støer NC, Rees JR, Robsahm TE (2018)

Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort

Br J Dermatol, 179 (3), 632-641

DOI 10.1111/bjd.16825 PubMed 29858512

 

Stenehjem JS, Veierød MB, Nilsen LT, Ghiasvand R, Johnsen B, Grimsrud TK, Babigumira R, Rees JR, Robsahm TE (2018)

Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort

Int J Cancer, 142 (4), 681-690

DOI 10.1002/ijc.31086 PubMed 28983909

 

Rounge TB, Umu SU, Keller A, Meese E, Ursin G, Tretli S, Lyle R, Langseth H (2018)

Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity

Sci Rep, 8 (1), 17650

DOI 10.1038/s41598-018-35974-4 PubMed 6281647

 

Perez-Cornago A, Appleby PN, Boeing H, Gil L, Kyrø C, Ricceri F, Murphy N, Trichopoulou A, Tsilidis KK, Khaw KT, Luben RN, Gislefoss RE, Langseth H, Drake I, Sonestedt E, Wallström P, Stattin P, Johansson A, Landberg R, Nilsson LM, Ozasa K, Tamakoshi A, Mikami K, Kubo T, Sawada N, et al. (2018)

Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls

Int J Cancer, 143 (11), 2677-2686

DOI 10.1002/ijc.31640 PubMed 6283047

 

Lerro CC, Jones RR, Langseth H, Grimsrud TK, Engel LS, Sjödin A, Choo-Wosoba H, Albert P, Ward MH (2018)

A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort

Environ Res, 165, 125-132

DOI 10.1016/j.envres.2018.04.012 PubMed 5999553

 

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE (2018)

Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study

BMJ Open, 8 (3), e019309

DOI 10.1136/bmjopen-2017-019309 PubMed 5884376

 

Fehlmann T, Backes C, Alles J, Fischer U, Hart M, Kern F, Langseth H, Rounge T, Umu SU, Kahraman M, Laufer T, Haas J, Staehler C, Ludwig N, Hübenthal M, Meder B, Franke A, Lenhof HP, Meese E, Keller A (2018)

A high-resolution map of the human small non-coding transcriptome

Bioinformatics, 34 (10), 1621-1628

DOI 10.1093/bioinformatics/btx814 PubMed 29281000

 

Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B (2018)

Large-scale intact glycopeptide identification by Mascot database search

Sci Rep, 8 (1), 2117

DOI 10.1038/s41598-018-20331-2 PubMed 5795011

 

Anderson KS, Mork J, Langseth H, Wallstrom G (2018)

Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodologic issues

Oral Oncol, 80, 93

DOI 10.1016/j.oraloncology.2018.02.013 PubMed 29606498

 

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, et al. (2017)

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men

PLoS One, 12 (12), e0187741

DOI 10.1371/journal.pone.0187741 PubMed 5744924

 

Stenehjem JS, Grimsrud TK, Rees JR, Vos L, Babigumira R, Veierød MB, Robsahm TE (2017)

A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival

BMJ Open, 7 (6), e014829

DOI 10.1136/bmjopen-2016-014829 PubMed 5623373

 

Schwartzbaum J, Wang M, Root E, Pietrzak M, Rempala GA, Huang RP, Johannesen TB, Grimsrud TK (2017)

A nested case-control study of 277 prediagnostic serum cytokines and glioma

PLoS One, 12 (6), e0178705

DOI 10.1371/journal.pone.0178705 PubMed 5464586

 

Schwartz GG, Tretli S, Vos L, Robsahm TE (2017)

Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort

Cancer Epidemiol, 49, 225-230

DOI 10.1016/j.canep.2017.07.004 PubMed 28732327

 

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G (2017)

Cohort Profile: The Janus Serum Bank Cohort in Norway

Int J Epidemiol, 46 (2), 403-404g

DOI 10.1093/ije/dyw027 PubMed 27063606

 

Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, Langseth H, Meese E (2017)

Sources to variability in circulating human miRNA signatures

RNA Biol, 14 (12), 1791-1798

DOI 10.1080/15476286.2017.1367888 PubMed 5731815

 

Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H (2017)

Cohort Profile Update: The Janus Serum Bank Cohort in Norway

Int J Epidemiol, 46 (4), 1101-1102f

DOI 10.1093/ije/dyw302 PubMed 28087783

 

Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L (2017)

Effect of multiple freeze-thaw cycles on selected biochemical serum components

Clin Chem Lab Med, 55 (7), 967-973

DOI 10.1515/cclm-2016-0892 PubMed 27987362

 

Brennan P, Perola M, van Ommen GJ, Riboli E (2017)

Chronic disease research in Europe and the need for integrated population cohorts

Eur J Epidemiol, 32 (9), 741-749

DOI 10.1007/s10654-017-0315-2 PubMed 5662668

 

Anderson KS, Wallstrom G, Langseth H, Posner M, Cheng JN, Alam R, Chowell D, Furre IE, Mork J (2017)

Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer

Oral Oncol, 73, 132-137

DOI 10.1016/j.oraloncology.2017.08.014 PubMed 5624546

 

Späth F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Björkblom B, Wibom C, Melin B (2016)

Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study

Tumour Biol, 37 (8), 11065-11072

DOI 10.1007/s13277-015-4742-y PubMed 4999462

 

Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, Engel LS (2016)

Bayes and empirical Bayes methods for reduced rank regression models in matched case-control studies

Biometrics, 72 (2), 584-595

DOI 10.1111/biom.12444 PubMed 4870158

 

Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A, et al. (2016)

Circulating Folate and Vitamin B(12) and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls

Eur Urol, 70 (6), 941-951

DOI 10.1016/j.eururo.2016.03.029 PubMed 5094800

 

Meyer HE, Støer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjørge T (2016)

Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men

PLoS One, 11 (3), e0151441

DOI 10.1371/journal.pone.0151441 PubMed 4795600

 

Malhotra J, Waterboer T, Pawlita M, Michel A, Cai Q, Zheng W, Gao YT, Lan Q, Rothman N, Langseth H, Grimsrud TK, Yuan JM, Koh WP, Wang R, Arslan AA, Zeleniuch-Jacquotte A, Boffetta P (2016)

Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers

Br J Cancer, 115 (9), 1131-1139

DOI 10.1038/bjc.2016.285 PubMed 5117783

 

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J (2016)

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer

Acta Oncol, 55 (7), 839-845

DOI 10.3109/0284186x.2016.1139178 PubMed 26878091

 

Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J (2016)

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study

Cancer Epidemiol Biomarkers Prev, 25 (4), 721-724

DOI 10.1158/1055-9965.Epi-15-1290 PubMed 26908428

 

Björkblom B, Wibom C, Jonsson P, Mörén L, Andersson U, Johannesen TB, Langseth H, Antti H, Melin B (2016)

Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk

Oncotarget, 7 (24), 37043-37053

DOI 10.18632/oncotarget.9242 PubMed 5095057

 

Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014

BMC Cancer, 16 (1), 799

DOI 10.1186/s12885-016-2832-x PubMed 5064906

 

Zigmont V, Garrett A, Peng J, Seweryn M, Rempala GA, Harris R, Holloman C, Gundersen TE, Ahlbom A, Feychting M, Johannesen TB, Grimsrud TK, Schwartzbaum J (2015)

Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma

Nutr Cancer, 67 (7), 1120-1130

DOI 10.1080/01635581.2015.1073757 PubMed 4827350

 

Wibom C, Späth F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Johannesen TB, Andersson U, Melin B (2015)

Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study

Cancer Epidemiol Biomarkers Prev, 24 (5), 810-816

DOI 10.1158/1055-9965.Epi-14-1106 PubMed 25713050

 

Schwartzbaum J, Seweryn M, Holloman C, Harris R, Handelman SK, Rempala GA, Huang RP, Burkholder B, Brandemihl A, Kallberg H, Johannesen TB, Ahlbom A, Feychting M, Grimsrud TK (2015)

Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma

PLoS One, 10 (9), e0137503

DOI 10.1371/journal.pone.0137503 PubMed 4564184

 

Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE (2015)

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples

Cancer Epidemiol Biomarkers Prev, 24 (9), 1381-1387

DOI 10.1158/1055-9965.Epi-15-0289 PubMed 26108462

 

Koutros S, Langseth H, Grimsrud TK, Barr DB, Vermeulen R, Portengen L, Wacholder S, Freeman LE, Blair A, Hayes RB, Rothman N, Engel LS (2015)

Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case-Control Study in the Norwegian Janus Serum Bank Cohort

Environ Health Perspect, 123 (9), 867-872

DOI 10.1289/ehp.1408245 PubMed 4559951

 

Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliövaara M, Helzlsouer KJ, Henderson BE, Hercberg S, et al. (2015)

Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies

Am J Clin Nutr, 102 (5), 1142-1157

DOI 10.3945/ajcn.115.114306 PubMed 4625592

 

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L (2015)

HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank

Int J Gynecol Cancer, 25 (9), 1608-1615

DOI 10.1097/igc.0000000000000532 PubMed 26501436

 

Gislefoss RE, Grimsrud TK, Mørkrid L (2015)

Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank

Clin Biochem, 48 (6), 364-369

DOI 10.1016/j.clinbiochem.2014.12.006 PubMed 25523301

 

Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, et al. (2015)

Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium

Cancer Epidemiol Biomarkers Prev, 24 (3), 520-531

DOI 10.1158/1055-9965.Epi-14-1009 PubMed 4355041

 

Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB (2015)

Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk

J Clin Oncol, 33 (18), 2041-2050

DOI 10.1200/jco.2014.59.1602 PubMed 4461805

 

Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE (2015)

Physical Activity and Risk of Male Breast Cancer

Cancer Epidemiol Biomarkers Prev, 24 (12), 1898-1901

DOI 10.1158/1055-9965.Epi-15-0588 PubMed 4670580

 

Støer NC, Meyer HE, Samuelsen SO (2014)

Reuse of controls in nested case-control studies

Epidemiology, 25 (2), 315-317

DOI 10.1097/ede.0000000000000057 PubMed 24487222

 

Faust H, Andersson K, Ekström J, Hortlund M, Robsahm TE, Dillner J (2014)

Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma

Int J Cancer, 134 (4), 844-848

DOI 10.1002/ijc.28419 PubMed 23922031

 

de Vogel S, Ulvik A, Meyer K, Ueland PM, Nygård O, Vollset SE, Tell GS, Gregory JF, 3rd, Tretli S, Bjørge T (2014)

Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway

Int J Cancer, 134 (1), 197-206

DOI 10.1002/ijc.28347 PubMed 23797698

 

Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, et al. (2014)

Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results

J Natl Cancer Inst, 106 (3), djt465

DOI 10.1093/jnci/djt465 PubMed 3975166

 

Meyer HE, Robsahm TE, Bjørge T, Brustad M, Blomhoff R (2013)

Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies

Am J Clin Nutr, 97 (1), 147-154

DOI 10.3945/ajcn.112.039222 PubMed 23193007

 

de Vogel S, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Nygård O, Vollset SE, Tell GS, Tretli S, Bjørge T (2013)

Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort

Int J Epidemiol, 42 (1), 201-210

DOI 10.1093/ije/dys199 PubMed 23508410

 

Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J (2013)

Prospective study of genital human papillomaviruses and nonmelanoma skin cancer

Int J Cancer, 133 (8), 1840-1845

DOI 10.1002/ijc.28188 PubMed 23553409

 

Tretli S, Schwartz GG, Torjesen PA, Robsahm TE (2012)

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study

Cancer Causes Control, 23 (2), 363-370

DOI 10.1007/s10552-011-9885-6 PubMed 3261400

 

Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK (2012)

Association between prediagnostic IgE levels and risk of glioma

J Natl Cancer Inst, 104 (16), 1251-1259

DOI 10.1093/jnci/djs315 PubMed 3424222

 

Langseth H, Gislefoss R, Ivar Martinsen J, Tretli S (2012)

Scientific scope of integrating research activities in the Janus Serum Bank and Cancer Registry of Norway

Norsk Epidemiologi, 21 (2)

DOI 10.5324/nje.v21i2.1492

 

Hustad S, Eussen S, Midttun Ø, Ulvik A, van de Kant PM, Mørkrid L, Gislefoss R, Ueland PM (2012)

Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism

Clin Chem, 58 (2), 402-410

DOI 10.1373/clinchem.2011.174490 PubMed 22194632

 

Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L (2012)

Stability of testosterone measured in male archival serum samples by two different methods

Scand J Clin Lab Invest, 72 (7), 555-562

DOI 10.3109/00365513.2012.705888 PubMed 22935045

 

Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J (2012)

Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer

Am J Epidemiol, 175 (7), 685-695

DOI 10.1093/aje/kwr373 PubMed 23553409

 

Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schüz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, et al. (2011)

AGRICOH: a consortium of agricultural cohorts

Int J Environ Res Public Health, 8 (5), 1341-1357

DOI 10.3390/ijerph8051341 PubMed 3108113

 

Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E (2011)

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis

RNA Biol, 8 (3), 506-516

DOI 10.4161/rna.8.3.14994 PubMed 21558792

 

Dahlström LA, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, Wiklund F, Skare GB, Eklund C, Sjölin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J (2011)

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer

Cancer Epidemiol Biomarkers Prev, 20 (12), 2541-2550

DOI 10.1158/1055-9965.Epi-11-0761 PubMed 21994401

 

Langseth H, Luostarinen T, Bray F, Dillner J (2010)

Ensuring quality in studies linking cancer registries and biobanks

Acta Oncol, 49 (3), 368-377

DOI 10.3109/02841860903447069 PubMed 20059313

 

Key TJ, Appleby PN, Reeves GK, Roddam AW (2010)

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

Lancet Oncol, 11 (6), 530-542

DOI 10.1016/s1470-2045(10)70095-4 PubMed 3113287

 

Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Mørkrid L, Ueland PM (2010)

Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years

J Nutr, 140 (3), 522-526

DOI 10.3945/jn.109.116418 PubMed 20071651

 

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010)

Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study

Br J Cancer, 102 (11), 1665-1669

DOI 10.1038/sj.bjc.6605675 PubMed 2883146

 

Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE (2009)

Association between serum 25(OH)D and death from prostate cancer

Br J Cancer, 100 (3), 450-454

DOI 10.1038/sj.bjc.6604865 PubMed 2658536

 

Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA (2009)

Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors

Environ Health Perspect, 117 (10), 1514-1519

DOI 10.1289/ehp.0800359 PubMed 2790503

 

Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, Andersen A, Jellum E, Dillner J (2009)

The Janus Serum Bank: From sample collection to cancer research

Cancer in Norway 2009

 

 

Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Löve A, Mahlamaki E, Thoresen S, Tryggvadóttir L, Wadell G, Youngman L, Lehtinen M (2009)

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks

Am J Epidemiol, 169 (4), 480-488

DOI 10.1093/aje/kwn354 PubMed 19074773

 

Gislefoss RE, Grimsrud TK, Mørkrid L (2009)

Stability of selected serum proteins after long-term storage in the Janus Serum Bank

Clin Chem Lab Med, 47 (5), 596-603

DOI 10.1515/cclm.2009.121 PubMed 19290843

 

Gislefoss R, Jellum E (2009)

The Janus serum bank and biomarkers of cancer

Norsk Epidemiologi, 16 (1)

DOI 10.5324/nje.v16i1.206

 

Vatten LJ, Holly JM, Gunnell D, Tretli S (2008)

Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway

Cancer Epidemiol Biomarkers Prev, 17 (8), 2097-2100

DOI 10.1158/1055-9965.Epi-08-0212 PubMed 18708402

 

Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K (2008)

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study

Lung Cancer, 61 (2), 235-243

DOI 10.1016/j.lungcan.2007.12.025 PubMed 18281122

 

Roddam AW, Allen NE, Appleby P, Key TJ (2008)

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

J Natl Cancer Inst, 100 (3), 170-183

DOI 10.1093/jnci/djm323 PubMed 6126902

 

Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M (2008)

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors

Ann Rheum Dis, 67 (6), 860-866

DOI 10.1136/ard.2007.073825 PubMed 17644543

 

Gislefoss RE, Grimsrud TK, Mørkrid L (2008)

Long-term stability of serum components in the Janus Serum Bank

Scand J Clin Lab Invest, 68 (5), 402-409

DOI 10.1080/00365510701809235 PubMed 18752145

 

Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J (2007)

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers

Acta Oncol, 46 (3), 286-307

DOI 10.1080/02841860701203545 PubMed 17450464

 

Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J (2007)

No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus

Int J Cancer, 121 (5), 1098-1102

DOI 10.1002/ijc.22770 PubMed 17471560

 

Kjaerheim K, Røe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Andersen A, Boffetta P, Pawlita M (2007)

Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples

Int J Cancer, 120 (11), 2459-2465

DOI 10.1002/ijc.22592 PubMed 17315193

 

Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE (2007)

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status

Gut, 56 (7), 918-925

DOI 10.1136/gut.2006.114504 PubMed 1994366

 

Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N (2007)

Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts

Cancer Res, 67 (11), 5545-5552

DOI 10.1158/0008-5472.Can-06-3906 PubMed 17545638

 

Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P (2006)

Serum adiponectin is not associated with risk of colorectal cancer

Cancer Epidemiol Biomarkers Prev, 15 (2), 401-402

DOI 10.1158/1055-9965.Epi-05-0836 PubMed 16492937

 

Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A (2006)

Serum cotinine level as predictor of lung cancer risk

Cancer Epidemiol Biomarkers Prev, 15 (6), 1184-1188

DOI 10.1158/1055-9965.Epi-06-0032 PubMed 16775179

 

Tedeschi R, Luostarinen T, De Paoli P, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J (2005)

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk

Br J Cancer, 93 (7), 834-837

DOI 10.1038/sj.bjc.6602751 PubMed 2361639

 

Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M (2005)

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study

Cancer Epidemiol Biomarkers Prev, 14 (12), 2952-2955

DOI 10.1158/1055-9965.Epi-05-0602 PubMed 16365015

 

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M (2005)

Chlamydial antibodies and risk of prostate cancer

Cancer Epidemiol Biomarkers Prev, 14 (2), 385-389

DOI 10.1158/1055-9965.Epi-03-0325 PubMed 15734962

 

Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM (2004)

Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort

Cancer Epidemiol Biomarkers Prev, 13 (12), 2175-2180

PubMed 15598777

 

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M (2004)

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries

Int J Cancer, 108 (1), 104-108

DOI 10.1002/ijc.11375 PubMed 14618623

 

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M (2004)

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study

Int J Cancer, 108 (3), 418-424

DOI 10.1002/ijc.11572 PubMed 14648709

 

Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E (2004)

Obesity and colon cancer: does leptin provide a link?

Int J Cancer, 109 (1), 149-152

DOI 10.1002/ijc.11668 PubMed 14735482

 

Luostarinen T, Lehtinen M, Bjørge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T (2004)

Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri

Eur J Cancer, 40 (7), 1058-1065

DOI 10.1016/j.ejca.2003.11.032 PubMed 15093583

 

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E (2004)

Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis

Anal Chem, 76 (15), 4406-4409

DOI 10.1021/ac049788k PubMed 15283579

 

Chiba H, Tretli S, Lund E, Wakai K, Takezaki T, Senoo H, Sonoda S, Tajima K (2004)

Lack of HTLV-I carriers in the Sami, an ethnic group living in the Arctic area in Norway

Asian Pac J Cancer Prev, 5 (1), 50-53

PubMed 15075005

 

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A (2004)

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study

Br J Cancer, 91 (10), 1829-1834

DOI 10.1038/sj.bjc.6602199 PubMed 2410048

 

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T (2003)

Plasma leptin is not associated with prostate cancer risk

Cancer Epidemiol Biomarkers Prev, 12 (5), 474-475

PubMed 12750247

 

Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC (2003)

Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer

Am J Obstet Gynecol, 189 (5), 1287-1292

DOI 10.1067/s0002-9378(03)00755-5 PubMed 14634555

 

Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J (2003)

Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later

Am J Obstet Gynecol, 188 (1), 49-55

DOI 10.1067/mob.2003.98 PubMed 12548195

 

Jellum E, Gislefoss RE (2003)

Serumbank "Janus" i kreftforskning

In Stokke O (Ed.), Fra håndverk til høyteknologi. Klinisk kjemi på Rikshospitalet fra 1953 til 2003 (pp. 403-415): Rikshospitalet Norge

 

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M (2002)

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study

Int J Cancer, 99 (1), 124-129

DOI 10.1002/ijc.10313 PubMed 11948503

 

Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V (2002)

A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas

Br J Cancer, 87 (2), 175-180

DOI 10.1038/sj.bjc.6600454 PubMed 2376113

 

Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinen M, J. D (2002)

Humant papillomavirus-infeksjon som risikofaktor for plateepitel-karsinom

Tidsskr Nor Laegeforen 2002, 122 (16), 1544-1548

 

Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M (2002)

Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries

Am J Epidemiol, 156 (8), 687-692

DOI 10.1093/aje/kwf098 PubMed 12370156

 

Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen S, Dillner J (2002)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study

Br J Cancer, 87 (1), 61-64

DOI 10.1038/sj.bjc.6600350 PubMed 2364291

 

Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001)

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

N Engl J Med, 344 (15), 1125-1131

DOI 10.1056/nejm200104123441503 PubMed 11297703

 

Høstmark AT, Glattre E, Jellum E (2001)

Effect of long-term storage on the concentration of albumin and free fatty acids in human sera

Scand J Clin Lab Invest, 61 (6), 443-447

DOI 10.1080/00365510152567077 PubMed 11681533

 

Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Närvänen A, Pukkala E, Thoresen S, Youngman L, Paavonen J (2001)

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

Jama, 285 (1), 47-51

DOI 10.1001/jama.285.1.47 PubMed 11150108

 

Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG, Jr., Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, Waters M, Butler MA, DiPietro E, Needham LL (2000)

Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women

Cancer Epidemiol Biomarkers Prev, 9 (12), 1357-1367

PubMed 11142422

 

Koskela P, Anttila T, Bjørge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J (2000)

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

Int J Cancer, 85 (1), 35-39

DOI 10.1002/(sici)1097-0215(20000101)85:1<35::aid-ijc6>3.0.co;2-a PubMed 10585579

 

Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T (2000)

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries)

Cancer Causes Control, 11 (9), 783-790

DOI 10.1023/a:1008976703797 PubMed 11075866

 

Luostarinen T, af Geijersstam V, Bjørge T, Eklund C, Hakama M, Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller JT, Thoresen S, Youngman LD, Dillner J, Lehtinen M (1999)

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11

Int J Cancer, 80 (6), 818-822

DOI 10.1002/(sici)1097-0215(19990315)80:6<818::aid-ijc4>3.0.co;2-t PubMed 10074912

 

Hansen S, Melby KK, Aase S, Jellum E, Vollset SE (1999)

Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study

Scand J Gastroenterol, 34 (4), 353-360

DOI 10.1080/003655299750026353 PubMed 10365894

 

Berg JP, Engeland A, Jellum E, Glattre E (1999)

Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study

Thyroid, 9 (3), 285-288

DOI 10.1089/thy.1999.9.285 PubMed 10211606

 

Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A (1999)

Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study

Int J Cancer, 82 (1), 1-5

DOI 10.1002/(sici)1097-0215(19990702)82:1<1::aid-ijc1>3.0.co;2-l PubMed 10360811

 

Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J (1997)

Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection

J Infect Dis, 176 (6), 1641-1644

DOI 10.1086/517346 PubMed 9395383

 

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E (1997)

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway

Cancer Epidemiol Biomarkers Prev, 6 (11), 967-969

PubMed 9367072

 

Jellum E, Dollekamp H, Brunsvig A, Gislefoss R (1997)

Diagnostic applications of chromatography and capillary electrophoresis

J Chromatogr B Biomed Sci Appl, 689 (1), 155-164

DOI 10.1016/s0378-4347(96)00333-7 PubMed 9061490

 

Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L (1997)

Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer

Int J Cancer, 71 (4), 545-551

DOI 10.1002/(sici)1097-0215(19970516)71:4<545::aid-ijc7>3.0.co;2-u PubMed 9178806

 

Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997)

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

J Natl Cancer Inst, 89 (17), 1293-1299

DOI 10.1093/jnci/89.17.1293 PubMed 9293920

 

Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J (1997)

A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway

Cancer Res, 57 (18), 3989-3992

 PubMed 9307283

 

Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S (1997)

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers

Bmj, 315 (7109), 646-649

DOI 10.1136/bmj.315.7109.646 PubMed 2127456

 

Jellum E, Dollekamp H, Blessum C (1996)

Capillary electrophoresis for clinical problem solving: analysis of urinary diagnostic metabolites and serum proteins

J Chromatogr B Biomed Appl, 683 (1), 55-65

DOI 10.1016/0378-4347(96)00132-6 PubMed 8876439

 

Jellum E, Andersen A, Baklien K, Dalen A, Iversen O, Lund-Larsen P, Theodorsen L, Orjasaeter H, Brunsvig A, Gislefoss R (1996)

Use of the Janus serum bank in cancer research

NORD Biotech 9, 43-52

 

 

Jellum E, Andersen A, Baklien K, Dalen A, Iversen O, Lund-Larsen P, Theodorsen L, Orjasaeter H (1996)

The use of the Janus serum bank in studies related to the environment and cancer

Norwegian Acad Sci Letters, 23-32

 

 

Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H (1995)

Experiences of the Janus Serum Bank in Norway

Environ Health Perspect, 103 Suppl 3 (Suppl 3), 85-88

DOI 10.1289/ehp.95103s385 PubMed 1519017

 

Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994)

Helicobacter pylori infection and gastric lymphoma

N Engl J Med, 330 (18), 1267-1271

DOI 10.1056/nejm199405053301803

 

Berg JP, Glattre E, Haldorsen T, Høstmark AT, Bay IG, Johansen AF, Jellum E (1994)

Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway

Cancer Causes Control, 5 (5), 433-439

DOI 10.1007/bf01694757 PubMed 7999965

 

Vatten LJ, Bjerve KS, Andersen A, Jellum E (1993)

Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway

Eur J Cancer, 29a (4), 532-538

DOI 10.1016/s0959-8049(05)80146-7 PubMed 8435206

 

Paus E, Theodorsen L, Engeland A (1993)

Prostate-specific antigen in serum from blood donors with subsequent prostate cancer diagnosis

Eur J Cancer, 29a (8), 1221-1222

DOI 10.1016/s0959-8049(05)80333-8 PubMed 7686023

 

Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H (1993)

The JANUS serum bank

Sci Total Environ, 139-140, 527-535

DOI 10.1016/0048-9697(93)90049-c PubMed 8272856

 

Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1991)

Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma

Int J Cancer, 49 (3), 387-393

DOI 10.1002/ijc.2910490313 PubMed 1655660

 

Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1991)

Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma

Cancer Causes Control, 2 (2), 125-131

DOI 10.1007/bf00053132 PubMed 1651778

 

Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1989)

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

N Engl J Med, 320 (11), 689-695

DOI 10.1056/nejm198903163201103 PubMed 2537928

 

Jellum E, Thorsrud AK (1989)

Profiling cells and body fluids--chromatography and two-dimensional electrophoresis as complementary techniques

J Chromatogr, 488 (1), 105-127

DOI 10.1016/s0378-4347(00)82942-4 PubMed 2715280

 

Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J (1989)

Prediagnostic serum selenium in a case-control study of thyroid cancer

Int J Epidemiol, 18 (1), 45-49

DOI 10.1093/ije/18.1.45 PubMed 2722382

 

Zurawski VR, Jr., Orjaseter H, Andersen A, Jellum E (1988)

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer

Int J Cancer, 42 (5), 677-680

DOI 10.1002/ijc.2910420507 PubMed 3182103

 

Thoresen SO, Myking O, Glattre E, Rootwelt K, Andersen A, Foss OP (1988)

Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer

Br J Cancer, 57 (1), 105-108

DOI 10.1038/bjc.1988.19 PubMed 2246681

 

Jellum E, Andersen A, Ørjasæter H, Foss O, Theodorsen L, Lund-Larsen P (1987)

The JANUS serum bank and early detection of cancer

Biochem Clin, 11, 191-195

 

 

Kotlar HK, Sanner T, Eker P, Pihl A, Orjasaeter H, Harvei S, Theodorsen L, Jellum E (1982)

Immune anti-tumor response in the preclinical period of lung cancer

Eur J Cancer Clin Oncol, 18 (3), 317-319

DOI 10.1016/0277-5379(82)90050-5 PubMed 7201399

 

Ørjasaeter H (1974)

The "Janus" serum research programme: a multipurpose project for retrospective as well as prospective investigations of cancer

Acta Pathol Microbiol Scand Suppl, Suppl 248, 175-179

PubMed 4451120